| D007114 |
Immunization |
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). |
Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations |
|
| D009522 |
Newcastle disease virus |
The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food. |
Avian Paramyxovirus 1,Paramyxovirus 1, Avian |
|
| D002522 |
Chlorocebus aethiops |
A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. |
African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys |
|
| D005434 |
Flow Cytometry |
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. |
Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell |
|
| D005822 |
Genetic Vectors |
DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. |
Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle |
|
| D000281 |
Administration, Intranasal |
Delivery of medications through the nasal mucosa. |
Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D014765 |
Viral Vaccines |
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. |
Viral Vaccine,Vaccine, Viral,Vaccines, Viral |
|
| D045473 |
Severe acute respiratory syndrome-related coronavirus |
A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus. |
HCoV-SARS,SARS Virus,SARS-Associated Coronavirus,SARS-CoV,SARS-CoV-1,SARS-like coronavirus,SARSr-CoV,SARSrCoV,Sarbecovirus,Severe Acute Respiratory Syndrome Virus,Severe acute respiratory syndrome coronavirus,SARS Coronavirus,SARS-Related Coronavirus,Urbani SARS-Associated Coronavirus,Coronavirus, SARS,Coronavirus, SARS-Associated,Coronavirus, SARS-Related,Coronavirus, Urbani SARS-Associated,SARS Associated Coronavirus,SARS Related Coronavirus,SARS like coronavirus,SARS-Associated Coronavirus, Urbani,SARS-like coronaviruses,SARSrCoVs,Sarbecoviruses,Severe acute respiratory syndrome related coronavirus,Urbani SARS Associated Coronavirus |
|
| D021821 |
Communicable Diseases, Emerging |
Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode. |
Infectious Diseases, Emerging,Communicable Diseases, Re-Emerging,Communicable Diseases, Reemerging,Infectious Diseases, Re-Emerging,Infectious Diseases, Reemerging,Communicable Disease, Emerging,Communicable Disease, Re-Emerging,Communicable Disease, Reemerging,Communicable Diseases, Re Emerging,Disease, Emerging Communicable,Disease, Emerging Infectious,Disease, Re-Emerging Communicable,Disease, Re-Emerging Infectious,Disease, Reemerging Communicable,Disease, Reemerging Infectious,Diseases, Emerging Communicable,Diseases, Emerging Infectious,Diseases, Re-Emerging Communicable,Diseases, Re-Emerging Infectious,Diseases, Reemerging Communicable,Diseases, Reemerging Infectious,Emerging Communicable Disease,Emerging Communicable Diseases,Emerging Infectious Disease,Emerging Infectious Diseases,Infectious Disease, Emerging,Infectious Disease, Re-Emerging,Infectious Disease, Reemerging,Infectious Diseases, Re Emerging,Re-Emerging Communicable Disease,Re-Emerging Communicable Diseases,Re-Emerging Infectious Disease,Re-Emerging Infectious Diseases,Reemerging Communicable Disease,Reemerging Communicable Diseases,Reemerging Infectious Disease,Reemerging Infectious Diseases |
|
-transparent.png){kind=logo}
